Break­ing: Pfiz­er's Covid-19 an­tivi­ral re­duces hos­pi­tal­iza­tions by 89%, could prove a for­mi­da­ble foe for Mer­ck­'s pill

Pfiz­er on Fri­day un­veiled sta­tis­ti­cal­ly sig­nif­i­cant ef­fi­ca­cy da­ta for its po­ten­tial Covid-19 pill among peo­ple who haven’t been hos­pi­tal­ized with the virus. The da­ta will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER